Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1

Vaccine

Volumn 28, Issue 18, 2010, Pages 3159-3170

  Khattar, Sunil K ^a   Collins, Peter L ^b   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Antibody responses; BHV 1 gD; NDV

Indexed keywords

BOVINE HERPES VIRUS VACCINE; GLYCOPROTEIN D; HYBRID PROTEIN; IMMUNOGLOBULIN G; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL CELL; ANTIBODY RESPONSE; ARTICLE; BOVINE HERPES VIRUS; CALF (BOVINE); CATTLE DISEASE; CHICKEN; CONTROLLED STUDY; EMBRYO; MUCOSAL IMMUNITY; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; VIRUS RECOMBINANT;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BLOOD; CATTLE; CATTLE DISEASES; CHICKENS; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, BOVINE; IMMUNITY, MUCOSAL; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; POULTRY DISEASES; VIRAL PROTEINS; VIRAL VACCINES; VIRULENCE;

EID: 77949655727     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.02.051     Document Type: Article

References (61)

1. van Drunen Littel-van den Hurk S., Parker M.D., Massie B., van den Hurk J.V., Harland R., Babiuk L.A., et al. Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV. Vaccine 11 1 (1993) 25-35
2. Li Y., van Drunen Littel-van den Hurk S., Babiuk L.A., and Liang X. Characterization of cell-binding properties of bovine herpesvirus 1 glycoproteins B, C, and D: identification of a dual cell-binding function of gB. J Virol 69 August (8) (1995) 4758-4768
3. Mettenleiter T.C. Herpesvirus assembly and egress. J Virol 76 February (4) (2002) 1537-1547
4. Yates W.D. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can J Comp Med 46 July (3) (1982) 225-263
5. Babiuk L.A., L'Italien J., van Drunen Littel-van den Hurk S., Zamb T., Lawman J.P., Hughes G., et al. Protection of cattle from bovine herpesvirus type I (BHV-1) infection by immunization with individual viral glycoproteins. Virology 159 July (1) (1987) 57-66
6. Chase C.C., Carter-Allen K., and Letchworth III G.J. The effect of bovine herpesvirus type 1 glycoproteins gI and gIII on herpesvirus infections. J Gen Virol 70 June (Pt 6) (1989) 1561-1569
7. van Drunen Littel-van den Hurk S., Gifford G.A., and Babiuk L.A. Epitope specificity of the protective immune response induced by individual bovine herpesvirus-1 glycoproteins. Vaccine 8 August (4) (1990) 358-368
8. Gao Y., Leary T.P., Eskra L., and Splitter G.A. Truncated bovine herpesvirus-1 glycoprotein I (gpI) initiates a protective local immune response in its natural host. Vaccine 12 February (2) (1994) 145-152
9. Zhu X., and Letchworth III G.J. Mucosal and systemic immunity to bovine herpesvirus-1 glycoprotein D confer resistance to viral replication and latency in cattle. Vaccine 14 January (1) (1996) 61-69
10. Denis M., Slaoui M., Keil G., Babiuk L.A., Ernst E., Pastoret P.P., et al. Identification of different target glycoproteins for bovine herpes virus type 1-specific cytotoxic T lymphocytes depending on the method of in vitro stimulation. Immunology 78 January (1) (1993) 7-13
11. Oliveira S.C., Harms J.S., Rosinha G.M., Rodarte R.S., Rech E.L., and Splitter G.A. Biolistic-mediated gene transfer using the bovine herpesvirus-1 glycoprotein D is an effective delivery system to induce neutralizing antibodies in its natural host. J Immunol Methods 245 November (1-2) (2000) 109-118
12. van Drunen Littel-van den Hurk S., Tikoo S.K., Liang X., and Babiuk L.A. Bovine herpesvirus-1 vaccines. Immunol Cell Biol 71 October (Pt 5) (1993) 405-420
13. Perez Filgueira D.M., Zamorano P.I., Dominguez M.G., Taboga O., Del Medico Zajac M.P., Puntel M., et al. Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine 21 October (27-30) (2003) 4201-4209
14. Gogev S., Georgin J.P., Schynts F., Vanderplasschen A., and Thiry E. Bovine herpesvirus 1 glycoprotein D expression in bovine upper respiratory tract mediated by a human adenovirus type 5. Vet Res 35 November-December (6) (2004) 715-721
15. Gogev S., Vanderheijden N., Lemaire M., Schynts F., D'Offay J., Deprez I., et al. Induction of protective immunity to bovine herpesvirus type 1 in cattle by intranasal administration of replication-defective human adenovirus type 5 expressing glycoprotein gC or gD. Vaccine 20 January (9-10) (2002) 1451-1465
16. Reddy P.S., Idamakanti N., Chen Y., Whale T., Babiuk L.A., Mehtali M., et al. Replication-defective bovine adenovirus type 3 as an expression vector. J Virol 73 November (11) (1999) 9137-9144
17. Zakhartchouk A.N., Pyne C., Mutwiri G.K., Papp Z., Baca-Estrada M.E., Griebel P., et al. Mucosal immunization of calves with recombinant bovine adenovirus-3: induction of protective immunity to bovine herpesvirus-1. J Gen Virol 80 May (Pt 5) (1999) 1263-1269
18. de Leeuw O., and Peeters B. Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol 80 January (Pt 1) (1999) 131-136
19. Krishnamurthy S., and Samal S.K. Nucleotide sequences of the trailer, nucleocapsid protein gene and intergenic regions of Newcastle disease virus strain Beaudette C and completion of the entire genome sequence. J Gen Virol 79 October (Pt 10) (1998) 2419-2424
20. Alexander D.J. Newcastle disease and other avian Paramyxoviridae infection. 10th ed. (1997), Iowa State University Press, Ames, IA
21. Alexander D.J. Newcastle disease. 3rd ed. (1989), American Association for Avian Pathologists, University of Pennsylvania, Kennett Square, PA
22. DiNapoli J.M., Kotelkin A., Yang L., Elankumaran S., Murphy B.R., Samal S.K., et al. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci USA 104 June (23) (2007) 9788-9793
23. Bukreyev A., Huang Z., Yang L., Elankumaran S., St Claire M., Murphy B.R., et al. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol 79 November (21) (2005) 13275-13284
24. Nakaya Y., Nakaya T., Park M.S., Cros J., Imanishi J., Palese P., et al. Induction of cellular immune responses to simian immunodeficiency virus gag by two recombinant negative-strand RNA virus vectors. J Virol 78 September (17) (2004) 9366-9375
25. Martinez-Sobrido L., Gitiban N., Fernandez-Sesma A., Cros J., Mertz S.E., Jewell N.A., et al. Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector. J Virol 80 February (3) (2006) 1130-1139
26. Nayak B., Rout S.N., Kumar S., Khalil M.S., Fouda M.M., Ahmed L.E., et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 4 8 (2009) e6509
27. Carnero E., Li W., Borderia A.V., Moltedo B., Moran T., and Garcia-Sastre A. Optimization of human immunodeficiency virus gag expression by Newcastle disease virus vectors for the induction of potent immune responses. J Virol 83 January (2) (2009) 584-597
28. DiNapoli J.M., Yang L., Suguitan Jr. A., Elankumaran S., Dorward D.W., Murphy B.R., et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 81 November (21) (2007) 11560-11568
29. Subbiah M., Yan Y., Rockemann D., and Samal S.K. Experimental infection of calves with Newcastle disease virus induces systemic and mucosal antibody responses. Arch Virol 153 6 (2008) 1197-1200
30. Huang Z., Krishnamurthy S., Panda A., and Samal S.K. High-level expression of a foreign gene from the most 3′-proximal locus of a recombinant Newcastle disease virus. J Gen Virol 82 July (Pt 7) (2001) 1729-1736
31. Rout S.N., and Samal S.K. The large polymerase protein is associated with the virulence of Newcastle disease virus. J Virol 82 August (16) (2008) 7828-7836
32. Raggo C., Fitzpatrick D.R., Babiuk L.A., and Liang X. Expression of bovine interleukin-1 beta in a bovine herpesvirus-1 vector: in vitro analysis. Virology 221 July (1) (1996) 78-86
33. Huang Z., Krishnamurthy S., Panda A., and Samal S.K. Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J Virol 77 August (16) (2003) 8676-8685
34. Krishnamurthy S., Huang Z., and Samal S.K. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 278 December (1) (2000) 168-182
35. Peeters B.P., Gruijthuijsen Y.K., de Leeuw O.S., and Gielkens A.L. Genome replication of Newcastle disease virus: involvement of the rule-of-six. Arch Virol 145 9 (2000) 1829-1845
36. Calain P., and Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 67 August (8) (1993) 4822-4830
37. Kozak M. Initiation of translation in prokaryotes and eukaryotes. Gene 234 July (2) (1999) 187-208
38. Avki S., Turutoglu H., Simsek A., and Unsal A. Clinical and immunological effects of Newcastle disease virus vaccine on bovine papillomatosis. Vet Immunol Immunopathol 98 March (1-2) (2004) 9-16
39. Dinapoli J.M., Ward J.M., Cheng L., Yang L., Elankumaran S., Murphy B.R., et al. Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Vaccine 27 March (10) (2009) 1530-1539
40. Bukreyev A., and Collins P.L. Newcastle disease virus as a vaccine vector for humans. Curr Opin Mol Ther 10 February (1) (2008) 46-55
41. Israel B.A., Herber R., Gao Y., and Letchworth III G.J. Induction of a mucosal barrier to bovine herpesvirus 1 replication in cattle. Virology 188 May (1) (1992) 256-264
42. Papp Z., Middleton D.M., Mittal S.K., Babiuk L.A., and Baca-Estrada M.E. Mucosal immunization with recombinant adenoviruses: induction of immunity and protection of cotton rats against respiratory bovine herpesvirus type 1 infection. J Gen Virol 78 November (Pt 11) (1997) 2933-2943
43. Reddy P.S., Idamakanti N., Pyne C., Zakhartchouk A.N., Godson D.L., Papp Z., et al. The immunogenicity and efficacy of replication-defective and replication-competent bovine adenovirus-3 expressing bovine herpesvirus-1 glycoprotein gD in cattle. Vet Immunol Immunopathol 76 October (3-4) (2000) 257-268
44. Jones C., and Chowdhury S. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Anim Health Res Rev 8 December (2) (2007) 187-205
45. Dubuisson J., Israel B.A., and Letchworth III G.J. Mechanisms of bovine herpesvirus type 1 neutralization by monoclonal antibodies to glycoproteins gI, gIII and gIV. J Gen Virol 73 August (Pt 8) (1992) 2031-2039
46. Liang X.P., Babiuk L.A., van Drunen Littel-van den Hurk S., Fitzpatrick D.R., and Zamb T.J. Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV. J Virol 65 March (3) (1991) 1124-1132
47. Merza M., Tibor S., Kucsera L., Bognar G., and Morein B. ISCOM of BHV-1 envelope glycoproteins protected calves against both disease and infection. Zentralbl Veterinarmed B 38 June (4) (1991) 306-314
48. Trudel M., Boulay G., Seguin C., Nadon F., and Lussier G. Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-ISCOM vaccine. Vaccine 6 December (6) (1988) 525-529
49. Bosch J.C., Kaashoek M.J., Kroese A.H., and van Oirschot J.T. An attenuated bovine herpesvirus 1 marker vaccine induces a better protection than two inactivated marker vaccines. Vet Microbiol 52 October (3-4) (1996) 223-234
50. van Drunen Littel-van den H., Braun R.P., Lewis P.J., Karvonen B.C., Baca-Estrada M.E., Snider M., et al. Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle. J Gen Virol 79 April (Pt 4) (1998) 831-839
51. Gupta P.K., Saini M., Gupta L.K., Rao V.D., Bandyopadhyay S.K., Butchaiah G., et al. Induction of immune responses in cattle with a DNA vaccine encoding glycoprotein C of bovine herpesvirus-1. Vet Microbiol 78 February (4) (2001) 293-305
52. Gao Y., Wang C., and Splitter G.A. Mapping T and B lymphocyte epitopes of bovine herpesvirus-1 glycoprotein B. J Gen Virol 80 October (Pt 10) (1999) 2699-2704
53. Caselli E., Boni M., Di Luca D., Salvatori D., Vita A., and Cassai E. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice. Comp Immunol Microbiol Infect Dis 28 March (2) (2005) 155-166
54. Gehrz R.C., Fuad S., Liu Y.N., and Bach F.H. HLA class II restriction of T helper cell response to cytomegalovirus (CMV). I. Immunogenetic control of restriction. J Immunol 138 May (10) (1987) 3145-3151
55. Glass E.J., Oliver R.A., and Spooner R.L. Variation in T cell responses to ovalbumin in cattle: evidence for Ir gene control. Anim Genet 21 1 (1990) 15-28
56. Glass E.J., Oliver R.A., Spooner R.L., and Bovine. T cells recognize antigen in association with MHC class II haplotypes defined by one-dimensional isoelectric focusing. Immunology 72 March (3) (1991) 380-385
57. Curtsinger J.M., Liu Y.N., Radeke R., Bryon M.K., Fuad S., Bach F.H., et al. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles. J Gen Virol 75 February (Pt 2) (1994) 301-307
58. Kahn J.S., Schnell M.J., Buonocore L., and Rose J.K. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology 254 February (1) (1999) 81-91
59. Kretzschmar E., Buonocore L., Schnell M.J., and Rose J.K. High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses. J Virol 71 August (8) (1997) 5982-5989
60. Schnell M.J., Buonocore L., Kretzschmar E., Johnson E., and Rose J.K. Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles. Proc Natl Acad Sci USA 93 October (21) (1996) 11359-11365
61. Bukreyev A., Yang L., Zaki S.R., Shieh W.J., Rollin P.E., Murphy B.R., et al. A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. J Virol 80 March (5) (2006) 2267-2279